Summary

  • Celestica's second-quarter revenue increased 62% year over year to $4.70 billion, led by its Connectivity & Cloud Solutions segment. First-half operating cash flow and free cash flow were positive even as receivables, inventory and capital spending rose.
  • The company completed a primary issue of 11.129 million shares and estimated net proceeds of $3.39 billion for working capital, capex and general purposes. The issue was large beside its July 22 share-count snapshot; with three unnamed CCS customers at 63% of Q2 revenue, the next test is cash and earnings per share rather than demand visibility alone.

The growth curve meets a balance sheet

The first evidence of Celestica's AI-era expansion is not a new factory announcement. It is the June 30 balance sheet: $3.40 billion of inventory and $3.34 billion of net receivables, alongside $535.7 million in cash. By the time management reported second-quarter results in late July, revenue had reached $4.70 billion, 62% above a year earlier. The company raised its 2026 forecast again. Then in August it sold more than 11 million new shares.

Taken separately, each development can look uncomplicated: demand is strong, sales are growing, and management is funding expansion. Taken together, they pose the more useful market question. How much capital must a contract manufacturer commit before the revenue it has reported becomes cash—and what return must the larger share base earn once the investment is deployed?

The mix of growth is concentrated. Connectivity & Cloud Solutions (CCS) generated $3.81 billion, or 81% of Q2 revenue, up 84% from a year before. It includes communications as well as enterprise servers and storage. Advanced Technology Solutions generated $888 million, up 8%. That makes the AI-related demand cycle important to Celestica, but CCS should not be read as a clean measure of AI orders. The filing does not disclose customer names or identify what portion of a customer's purchases relate to AI infrastructure.

That limit matters because three customers, all in CCS, represented 32%, 17% and 14% of total revenue in the quarter. Together that is 63%; the top ten represented 83%. Those figures show exposure to a small number of large relationships, not that any named hyperscaler supplied the orders or that 63% of revenue was AI-related. The disclosure gives investors a concentration boundary while leaving the program-level bridge unavailable.

Cash is positive; the cycle still needs funding

Growth pulled more money through operating working capital. Net receivables rose $700 million from year-end, while inventory rose $1.21 billion. The company says the inventory increase primarily reflected business growth, mostly in CCS. Its quarterly indicators put days in receivables at 63 and days in inventory at 67. These are not, by themselves, signs of deteriorating collections or obsolete stock: volumes, payment terms, supplier timing and product mix all affect the balances. They do show why a fast-growing manufacturer can need financing ahead of the customer cash that follows shipment and acceptance.

The cash-flow statement prevents an easy distress narrative. During the first half, Celestica generated $767 million of cash from operations, spent $493 million on capital expenditure and reported $285 million of non-GAAP free cash flow. A year earlier, the corresponding figures were $283 million, $69 million and $214 million. Payables and other timing effects contributed to the working-capital bridge. Celestica defines free cash flow as operating cash less net purchases of property, plant and equipment and cautions that it is not residual cash available for every discretionary use.

Capital spending nevertheless moved sharply higher, from $69 million in the first half of 2025 to $493 million in the first half of 2026. Celestica says it was supporting CCS growth and manufacturing capacity, including in Thailand and the United States. More production capability can support programs with customer demand and improve throughput, but the public filings do not map the proceeds of the later offering to a particular facility or order. Investment arrives before its return is observable; demand projections do not themselves establish utilization or cash collection.

Profit measures tell a similarly mixed story without contradicting each other. Q2 GAAP gross margin was 12.3%, down from 12.8%, while adjusted operating margin rose to 8.2% from 7.4%. The first subtracts cost of sales; the second also reflects operating expenses and uses a non-GAAP adjustment set. Rising adjusted operating margin is evidence of operating leverage, while a lower gross margin means that the company is not converting each revenue dollar into a larger gross-profit percentage. Neither measure alone settles the return on new capacity.

What the share sale says—and does not

Celestica announced a $3 billion treasury offering on August 5, priced 9,677,419 shares at $310, and the underwriters exercised their option for another 1,451,612. The August 7 completion release says 11,129,031 shares were sold, for about $3.45 billion gross before discounts and expenses. The SEC filing estimated approximately $3.39 billion net and said the company expected to use proceeds for working capital, capital spending and general purposes.

That is a financing decision, not evidence that operations could not fund themselves. The positive first-half cash generation is part of the same record. Issuing equity can supply long-duration capital without adding contractual interest or repayment obligations; it also gives existing shareholders a smaller percentage claim on each future dollar of earnings unless those dollars grow enough to offset the expanded base.

The scale can be made legible with a dated comparison. Celestica reported 114,982,086 shares outstanding as of July 22. The 11.129 million shares sold were equal to about 9.7% of that snapshot. This is not an October share count, and it does not account for other share movements after July 22. It does show why an impressive revenue-growth rate cannot by itself answer the per-share question. The relevant measure is not only how much the company sells, but how much operating cash and durable earnings it produces after the new capital is put to work and across the larger share base.

Management's raised 2026 outlook—$20.5 billion in revenue, $11.30 adjusted EPS, 8.4% adjusted operating margin and $600 million non-GAAP free cash flow—reflects stronger customer forecasts and improved component supply, according to its release. Its expectation that 2027 growth will accelerate is also management's forecast. It is useful evidence of visibility, but the release does not convert that visibility into a customer-by-customer contracted backlog. New program wins, supply and customer deployment plans remain execution variables.

For now, the record supports two statements at once: the demand wave is producing material revenue and cash, and scaling it is tying up more assets while increasing the share base. The second statement does not cancel the first; the first does not make the second irrelevant. The cash-return test is whether receivables and inventory grow more slowly than sales over time, capital spending supports utilized capacity, margins hold as programs scale, and free cash flow and earnings per share rise after the financing.

Sources